NASDAQ · Drug Manufacturers - Specialty & Generic

BioCryst Pharmaceuticals Inc (BCRX)

$8.12 -2.05%

Add alert

30 Oversold Daily RSI (14) · 11 Sep 2026

Moving averages

SMA 200$8.60-5.58%

Company profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Market cap$2.07B

P/E ratioNone

EPS$-1.40

Beta0.564

Dividend yield0.00%

52-week high$11.22

52-week low$6.00

Similar stocks in Drug Manufacturers - Specialty & Generic

HIMS Hims & Hers Health Inc - Class A RSI 43 CGC Canopy Growth Corporation RSI 36 BFRI Biofrontera Inc RSI 60 TLRY Tilray Brands Inc - Class 2 RSI 33 LNTH Lantheus Holdings Inc RSI 43 ACB Aurora Cannabis Inc RSI 53 INM InMed Pharmaceuticals Inc RSI 37 ORGO Organogenesis Holdings Inc - Class A RSI 29 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52

Free forever

RSI alerts for BCRX

Get an email the moment BioCryst Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 6:34 AM EDT